Intuitive Surgical Reports Q3 2026 Growth Driven by System Placements and Procedure Volume
Intuitive Surgical (ISRG) delivered strong third-quarter 2026 results, reporting total revenue of $3.05 billion, a 22% increase year-over-year. This growth was fueled by significant increases in procedure volumes—specifically a 14% rise in da Vinci procedures and a 31% surge in Ion procedures—alongside robust system placements. The company's non-GAAP EPS grew 25% to $3.00, benefiting from operational leverage and higher revenue. Despite the strong performance, the company recorded a one-time $450 million charge to settle an antitrust class action lawsuit regarding third-party servicing. Management also noted strategic pricing reductions for benign procedures to expand market access, which may impact future revenue per procedure. While international growth remains strong, particularly in Japan and Europe, management cautioned that the operating environment in China continues to present challenges.
Tickers: $ISRG
Topics: Operating Margin Procedure Volume Revenue Growth System Placements
Read the full article at Motley Fool
Part of the story Philip Morris International Reports Strong Q3 2026 Results Driven by Smoke-Free Growth (6 articles)